Pipeline within a Product
Lysolipid Thermally Sensitive Liposomes, or LTSL’s, are a unique liposomal technology that allows for the triggered release of a drug payload through low temperature (just above body temperature) heat activation. Used in combination with heat therapy, this concentrates therapy directly within the treatment area.
Celsion is a late-stage biopharmaceutical company dedicated to the development of innovative, targeted therapies that address unmet medical needs in oncology. By applying our unique heat-activated liposomal drug delivery system to proven anti-cancer agents, we can deliver high concentrations of chemotherapeutics directly to the tumor site, with the ultimate goal of improving patient outcomes.